Bradmer Pharmaceuticals
Industry
- Pharmaceuticals
Latest on Bradmer Pharmaceuticals
IN VITRO DIAGNOSTICS Mergers & Acquisitions PDI Inc. Interpace Diagnostics LLC RedPath Integrated Pathology Inc. PDI Inc. acquired molecular diagnostics company RedPath Integrated Pathology Inc.
Financings During the final quarter of 2014, start-up companies raised a total of $1.5 billion, a 23% jump from the previous quarter’s record-high $1.2 billion. Q4 2014’s total is now the largest star
Financings Fourth-quarter 2014 biopharma financings reached $8.8 billion, a bump up of 54% over Q3’s $5.7 billion. Q4 was the second-largest of the year (behind Q1’s $9.8 billion) in dollars raised –
Biopharmaceutical company Bradmer Pharmaceuticals , which specialises in the development and commercialisation of cancer therapies, has appointed Dr Donald Kufe and Charles Lilly to its board of di